Related Experiment Video
Updated: Mar 6, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
Leukocytoclastic Vasculitis Induced by Dalbavancin: A Case Report
Vincenzo Scaglione1, Marco Cola1, Lolita Sasset1
1Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy.
Dalbavancin, an antibiotic for serious infections, can rarely cause leukocytoclastic vasculitis (LV). This case report details a patient who developed LV after dalbavancin treatment, highlighting a potential adverse effect for clinicians to monitor.
Area of Science:
- Dermatology
- Infectious Diseases
- Pharmacology
Background:
- Dalbavancin is a lipoglycopeptide antibiotic effective against gram-positive bacteria, including MRSA.
- It offers advantages like once-weekly dosing and good tolerability for complex infections.
- This study focuses on a rare adverse reaction to dalbavancin.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Endocarditis I: Introduction
Endocarditis III: Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Endocarditis IV: Nursing Management

